The role of tissue factor pathway inhibitor in tumor growth and metastasis.
暂无分享,去创建一个
Shaker A Mousa | S. Mousa | Ali Amirkhosravi | T. Meyer | M. Dávila | J. Francis | A. Amirkhosravi | John L Francis | Mildred Amaya | Monica Davila | Todd Meyer | Theresa Robson | M. Amaya | T. Robson | Mónica Dávila | Theresa Robson
[1] G. Broze,et al. Comparison of cell‐surface TFPIα and β , 2005, Journal of thrombosis and haemostasis : JTH.
[2] G. Nicolson,et al. In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2 , 2004, Clinical & Experimental Metastasis.
[3] Y. Nemerson,et al. Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofactor. , 1985, Thrombosis research.
[4] J. Francis,et al. Effect of Antihemostatic Agents on Experimental Tumor Dissemination , 2002, Seminars in thrombosis and hemostasis.
[5] M. Levine,et al. Epidemiology of Thrombosis in Cancer , 2001, Acta Haematologica.
[6] E. Abraham. Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis. , 2000, Critical care medicine.
[7] J. S. Rao,et al. Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro. , 2001, International journal of oncology.
[8] W. Konigsberg,et al. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] P. Nawroth,et al. Molecular mechanisms linking thrombosis and angiogenesis in cancer. , 1997, Trends in cardiovascular medicine.
[10] B. Furie,et al. Cancer-associated thrombosis. , 2006, Blood cells, molecules & diseases.
[11] M. Stack,et al. HT‐1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix‐associated serine protease inhibitor TFPI‐2/33 kDa MSPI , 1998, International journal of cancer.
[12] H. Saito,et al. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[13] W. Ruf,et al. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. , 1998, The Journal of clinical investigation.
[14] T. Bugge,et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. , 2000, Blood.
[15] H. Itoh,et al. Pancreatic cancer complicated by disseminated intravascular coagulation associated with production of tissue factor , 2001, Journal of Gastroenterology.
[16] J. Rak,et al. The hemostatic system and angiogenesis in malignancy. , 2001, Neoplasia.
[17] M. Donati,et al. Blood Clotting Activation, Angiogenesis and Tumor Metastasis: Any Role for TFPI? , 2002, Thrombosis and Haemostasis.
[18] W. Kisiel,et al. The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice. , 2004, Blood.
[19] T. Hembrough,et al. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. , 2003, Cancer research.
[20] O. Olsen,et al. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor. , 1996, European journal of biochemistry.
[21] M. Belting,et al. Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1. , 2005, Blood.
[22] V. Kakkar,et al. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[23] O. Matsubara,et al. Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis , 1999, British Journal of Cancer.
[24] Y. Miyagi,et al. A Role for Tissue Factor in Cell Adhesion and Migration Mediated by Interaction with Actin-binding Protein 280 , 1998, The Journal of cell biology.
[25] A. Mamourian,et al. Low-molecular-weight heparin and cancer. , 2000, Seminars in thrombosis and hemostasis.
[26] J. McNiff,et al. Ancylostoma caninum Anticoagulant Peptide Blocks Metastasis In Vivo and Inhibits Factor Xa Binding to Melanoma Cells In Vitro , 1998, Thrombosis and Haemostasis.
[27] M. Prins,et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] J. Birktoft,et al. Structure and Biology of Tissue Factor Pathway Inhibitor , 2001, Thrombosis and Haemostasis.
[29] W Ruf,et al. Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. , 2001, Blood.
[30] G. Fuller,et al. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[31] U. Pendurthi,et al. Microvesicle‐associated tissue factor and Trousseau's syndrome , 2007, Journal of thrombosis and haemostasis : JTH.
[32] J. Miletich,et al. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor , 1988 .
[33] J. Oliver,et al. TFPIβ, a Second Product from the Mouse Tissue Factor Pathway Inhibitor (TFPI) Gene , 1999, Thrombosis and Haemostasis.
[34] W. Kisiel,et al. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Mousa,et al. Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin , 2006, Thrombosis and Haemostasis.
[36] P. Carmeliet,et al. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling , 2004, Nature Medicine.
[37] D. Dinh,et al. A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas. , 2001, International journal of oncology.
[38] Y. Nemerson,et al. Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor. , 1990, Blood.
[39] J. Miletich,et al. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. , 1989, The Journal of biological chemistry.
[40] B. Su,et al. Tissue factor expression and angiogenesis in human glioma. , 2002, Clinical biochemistry.
[41] G. Broze,et al. Glycosyl Phosphatidylinositol Anchorage of Tissue Factor Pathway Inhibitor , 2003, Circulation.
[42] S. Nakamura,et al. Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration , 2000, British Journal of Cancer.
[43] W. Kisiel,et al. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. , 1996, Biochemistry.
[44] R. Gerard,et al. Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis. , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[45] A. Lindahl,et al. Release of extrinsic pathway inhibitor after heparin injection: increased response in cancer patients. , 1990, Thrombosis research.
[46] C. Bokemeyer,et al. Plasma tissue factor antigen in localized prostate cancer: Distribution, clinical significance and correlation with haemostatic activation markers , 2007, Thrombosis and Haemostasis.
[47] Susan G. Brown,et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor , 1989, Nature.
[48] C. Gondi,et al. Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line. , 2006, International journal of oncology.
[49] D. Strickland,et al. Tissue Factor Pathway Inhibitor Inhibits Endothelial Cell Proliferation via Association with the Very Low Density Lipoprotein Receptor* , 2001, The Journal of Biological Chemistry.
[50] J. Miletich,et al. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. , 1988, The Journal of biological chemistry.
[51] Y. Nemerson,et al. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein , 2003, Nature Medicine.
[52] T. Luther,et al. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. , 1994, The Journal of clinical investigation.
[53] J. Kuratsu,et al. Expression of tissue factor in glioma. , 1996, Noshuyo byori = Brain tumor pathology.
[54] W. Kisiel,et al. Distribution of Tissue Factor Pathway Inhibitor in Normal and Malignant Human Tissues , 1993, Thrombosis and Haemostasis.
[55] Y. Miyagi,et al. Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor. , 1999, The Journal of clinical investigation.
[56] J. Badimón,et al. Blood-borne tissue factor: another view of thrombosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[57] F. Siddiqui,et al. Tissue Factor Pathway Inhibitor Reduces Experimental Lung Metastasis of B16 Melanoma , 2002, Thrombosis and Haemostasis.
[58] H. Dvorak. Thrombosis and cancer. , 1987, Human pathology.
[59] C. Ettelaie,et al. The role of the C‐terminal domain in the inhibitory functions of tissue factor pathway inhibitor , 1999, FEBS letters.
[60] D. Strickland,et al. Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity. , 2004, Blood.
[61] J. Willerson,et al. Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[62] S. Eichinger,et al. Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer , 2006, Thrombosis and Haemostasis.
[63] H. Versteeg,et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling , 2006, Proceedings of the National Academy of Sciences.
[64] U. Pendurthi,et al. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. , 2004, Blood.
[65] W. Ruf,et al. Protease-activated Receptor 2-dependent Phosphorylation of the Tissue Factor Cytoplasmic Domain* , 2004, Journal of Biological Chemistry.
[66] C. Sprung,et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. , 2003, JAMA.
[67] 中崎 隆弘. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer , 2003 .
[68] C. N. Rao,et al. A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion , 2001, Oncogene.
[69] S. Mousa,et al. Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor , 2004, Thrombosis and Haemostasis.
[70] Nong Zhang,et al. Molecular design and characterization of recombinant long half-life mutants of human tissue factor pathway inhibitor , 2005, Thrombosis and Haemostasis.
[71] P. Comp,et al. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. , 1993, Blood.
[72] A. Lindahl,et al. High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer. , 1989, Acta chirurgica Scandinavica.
[73] A. Takeshita,et al. Adenovirus-mediated local expression of human tissue factor pathway inhibitor eliminates shear stress-induced recurrent thrombosis in the injured carotid artery of the rabbit. , 1999, Circulation research.
[74] G. Broze,et al. Role for the Kunitz-3 Domain of Tissue Factor Pathway Inhibitor-&agr; in Cell Surface Binding , 2004, Circulation.
[75] J. Sevinsky,et al. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor- dependent coagulation pathway , 1996, The Journal of cell biology.
[76] M. Amirkhosravi,et al. Coagulation Activation by MC28 Fibrosarcoma Cells Facilitates Lung Tumor Formation , 1995, Thrombosis and Haemostasis.
[77] K. Tamirisa,et al. Tissue factor pathway inhibitor attenuates procoagulant activity and upregulation of tissue factor at the site of balloon-induced arterial injury in pigs. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[78] J. Rak,et al. Shedding of tissue factor (TF)‐containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells , 2004, Journal of thrombosis and haemostasis : JTH.
[79] H. Hillen,et al. Thrombosis in cancer patients. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[80] S. Mousa. Low-molecular-weight heparins in thrombosis and cancer: emerging links. , 2006, Cardiovascular drug reviews.
[81] Y. Miyagi,et al. cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2. , 1994, Journal of biochemistry.
[82] P. Nawroth,et al. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[83] J. Hansen,et al. Heparin Induces Synthesis and Secretion of Tissue Factor Pathway Inhibitor from Endothelial Cells In Vitro , 2000, Thrombosis and Haemostasis.
[84] Reinhold Förster,et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.
[85] C. Bokemeyer,et al. Experimental metastasis and primary tumor growth in mice with hemophilia A , 2006, Journal of thrombosis and haemostasis : JTH.